Modern Myoma Treatment in the Last 20 Years: A Review of the Literature
Myomas, also known as fibroids, are a specific characteristic of the human species. No other primates develop fibroids. At a cellular level, myomas are benign hyperplastic lesions of uterine smooth muscle cells. There are interesting theoretical concepts that link the development of myomas in humans...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/4593875 |
id |
doaj-aca88a745ee54a1793a75be3f93fc301 |
---|---|
record_format |
Article |
spelling |
doaj-aca88a745ee54a1793a75be3f93fc3012020-11-25T00:23:24ZengHindawi LimitedBioMed Research International2314-61332314-61412018-01-01201810.1155/2018/45938754593875Modern Myoma Treatment in the Last 20 Years: A Review of the LiteratureAhmed El-Balat0Rudy Leon DeWilde1Iryna Schmeil2Morva Tahmasbi-Rad3Sandra Bogdanyova4Ali Fathi5Sven Becker6Department of Gynecology and Obstetrics, Goethe-University, Frankfurt, GermanyClinic of Gynecology, Obstetrics and Gynecological Oncology, Pius Hospital, University Hospital for Gynecology, Carl von Ossietzky University Medical School, Oldenburg, GermanyDepartment of Gynecology and Obstetrics, Goethe-University, Frankfurt, GermanyDepartment of Gynecology and Obstetrics, Goethe-University, Frankfurt, GermanyDepartment of Gynecology and Obstetrics, Goethe-University, Frankfurt, GermanyDepartment of Gynecology and Obstetrics, Goethe-University, Frankfurt, GermanyDepartment of Gynecology and Obstetrics, Goethe-University, Frankfurt, GermanyMyomas, also known as fibroids, are a specific characteristic of the human species. No other primates develop fibroids. At a cellular level, myomas are benign hyperplastic lesions of uterine smooth muscle cells. There are interesting theoretical concepts that link the development of myomas in humans with the highly specific process of childbirth from an upright position and the resulting need for greatly increased “expulsive” forces during labor. Myomas might be the price our species pays for our bipedal and highly intelligent existence. Myomas affect, with some variability, all ethnic groups and approximately 50% of all women during their lifetime. While some remain asymptomatic, myomas can cause significant and sometimes life-threatening uterine bleeding, pain, infertility, and, in extreme cases, ureteral obstruction and death. Traditionally, over 50% of all hysterectomies were performed for fibroids, leading to a significant healthcare burden. In this article, we review the developments of the past 20 years with regard to multiple new treatment strategies that have evolved during this time.http://dx.doi.org/10.1155/2018/4593875 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ahmed El-Balat Rudy Leon DeWilde Iryna Schmeil Morva Tahmasbi-Rad Sandra Bogdanyova Ali Fathi Sven Becker |
spellingShingle |
Ahmed El-Balat Rudy Leon DeWilde Iryna Schmeil Morva Tahmasbi-Rad Sandra Bogdanyova Ali Fathi Sven Becker Modern Myoma Treatment in the Last 20 Years: A Review of the Literature BioMed Research International |
author_facet |
Ahmed El-Balat Rudy Leon DeWilde Iryna Schmeil Morva Tahmasbi-Rad Sandra Bogdanyova Ali Fathi Sven Becker |
author_sort |
Ahmed El-Balat |
title |
Modern Myoma Treatment in the Last 20 Years: A Review of the Literature |
title_short |
Modern Myoma Treatment in the Last 20 Years: A Review of the Literature |
title_full |
Modern Myoma Treatment in the Last 20 Years: A Review of the Literature |
title_fullStr |
Modern Myoma Treatment in the Last 20 Years: A Review of the Literature |
title_full_unstemmed |
Modern Myoma Treatment in the Last 20 Years: A Review of the Literature |
title_sort |
modern myoma treatment in the last 20 years: a review of the literature |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6133 2314-6141 |
publishDate |
2018-01-01 |
description |
Myomas, also known as fibroids, are a specific characteristic of the human species. No other primates develop fibroids. At a cellular level, myomas are benign hyperplastic lesions of uterine smooth muscle cells. There are interesting theoretical concepts that link the development of myomas in humans with the highly specific process of childbirth from an upright position and the resulting need for greatly increased “expulsive” forces during labor. Myomas might be the price our species pays for our bipedal and highly intelligent existence. Myomas affect, with some variability, all ethnic groups and approximately 50% of all women during their lifetime. While some remain asymptomatic, myomas can cause significant and sometimes life-threatening uterine bleeding, pain, infertility, and, in extreme cases, ureteral obstruction and death. Traditionally, over 50% of all hysterectomies were performed for fibroids, leading to a significant healthcare burden. In this article, we review the developments of the past 20 years with regard to multiple new treatment strategies that have evolved during this time. |
url |
http://dx.doi.org/10.1155/2018/4593875 |
work_keys_str_mv |
AT ahmedelbalat modernmyomatreatmentinthelast20yearsareviewoftheliterature AT rudyleondewilde modernmyomatreatmentinthelast20yearsareviewoftheliterature AT irynaschmeil modernmyomatreatmentinthelast20yearsareviewoftheliterature AT morvatahmasbirad modernmyomatreatmentinthelast20yearsareviewoftheliterature AT sandrabogdanyova modernmyomatreatmentinthelast20yearsareviewoftheliterature AT alifathi modernmyomatreatmentinthelast20yearsareviewoftheliterature AT svenbecker modernmyomatreatmentinthelast20yearsareviewoftheliterature |
_version_ |
1725357256413806592 |